长期生存-话题@MedSci

#长期生存#

69篇内容 | 2439人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1618333, encodeId=0d45161833371, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=JAHA：左心室心肌致密化不全患者的长期生存率, objectType=article, longId=205792, objectId=6cf4205e92c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cf4205e92c8, replyNumber=0, likeNumber=63, createdTime=2021-01-17, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cf4205e92c8, moduleTitle=JAHA：左心室心肌致密化不全患者的长期生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cf4205e92c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618332, encodeId=424716183325b, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=J Gastroenterology: 肝硬化患者对托伐普坦的持久反应可提高无复发的长期生存率, objectType=article, longId=204151, objectId=d99f20415102, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d99f20415102, replyNumber=0, likeNumber=86, createdTime=2020-12-07, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d99f20415102, moduleTitle=J Gastroenterology: 肝硬化患者对托伐普坦的持久反应可提高无复发的长期生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d99f20415102)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618331, encodeId=7c18161833158, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Bluebird突破性基因疗法Lenti-D申请上市！改善致死罕见病CALD患者长期生存结局, objectType=article, longId=201693, objectId=ec9320169308, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec9320169308, replyNumber=0, likeNumber=62, createdTime=2020-10-06, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec9320169308, moduleTitle=Bluebird突破性基因疗法Lenti-D申请上市！改善致死罕见病CALD患者长期生存结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec9320169308)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618330, encodeId=51621618330d5, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Br J Cancer：III期临床试验：选择性淋巴结照射和或厄洛替尼联合放化疗改善局部晚期食道鳞状细胞癌患者长期生存率, objectType=article, longId=201182, objectId=099320118291, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=099320118291, replyNumber=0, likeNumber=75, createdTime=2020-09-26, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=099320118291, moduleTitle=Br J Cancer：III期临床试验：选择性淋巴结照射和或厄洛替尼联合放化疗改善局部晚期食道鳞状细胞癌患者长期生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=099320118291)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618329, encodeId=48e3161832978, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Thorax：无创通气患者的长期生存结局, objectType=article, longId=200739, objectId=5f41200e391c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f41200e391c, replyNumber=0, likeNumber=170, createdTime=2020-09-18, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f41200e391c, moduleTitle=Thorax：无创通气患者的长期生存结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f41200e391c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618328, encodeId=57121618328df, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=NEJM：Dabrafenib联合Trametinib 治疗III期黑色素瘤患者长期生存数据喜人, objectType=article, longId=200218, objectId=b6bb200218dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6bb200218dc, replyNumber=0, likeNumber=80, createdTime=2020-09-05, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6bb200218dc, moduleTitle=NEJM：Dabrafenib联合Trametinib 治疗III期黑色素瘤患者长期生存数据喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6bb200218dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618327, encodeId=8f09161832ec9, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Lancet:80岁以上高龄非ST升高的心肌梗死患者接受侵入性治疗后对长期生存有益, objectType=article, longId=200052, objectId=e9e820005269, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9e820005269, replyNumber=0, likeNumber=55, createdTime=2020-09-01, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9e820005269, moduleTitle=Lancet:80岁以上高龄非ST升高的心肌梗死患者接受侵入性治疗后对长期生存有益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9e820005269)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618326, encodeId=9f8616183261e, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=J Gastroenterology：对托伐普坦的持久反应可改善肝硬化的长期生存质量, objectType=article, longId=199977, objectId=93bf1999e730, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93bf1999e730, replyNumber=0, likeNumber=81, createdTime=2020-08-29, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93bf1999e730, moduleTitle=J Gastroenterology：对托伐普坦的持久反应可改善肝硬化的长期生存质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93bf1999e730)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618325, encodeId=780f1618325ec, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Neurology：长期生存的散发型克雅病1例, objectType=article, longId=199721, objectId=10bc199e213c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10bc199e213c, replyNumber=0, likeNumber=76, createdTime=2020-08-22, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10bc199e213c, moduleTitle=Neurology：长期生存的散发型克雅病1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10bc199e213c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618324, encodeId=8ca7161832419, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Thorax：家庭可支配收入与肺癌切除术后的长期生存率, objectType=article, longId=196226, objectId=f8a419622632, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8a419622632, replyNumber=0, likeNumber=77, createdTime=2020-06-23, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8a419622632, moduleTitle=Thorax：家庭可支配收入与肺癌切除术后的长期生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8a419622632)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618323, encodeId=252d161832350, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=赵明芳教授：达可替尼有望助力患者实现高质量长期生存, objectType=article, longId=194407, objectId=af8f19440ecd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af8f19440ecd, replyNumber=0, likeNumber=86, createdTime=2020-05-21, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af8f19440ecd, moduleTitle=赵明芳教授：达可替尼有望助力患者实现高质量长期生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af8f19440ecd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618322, encodeId=7a7c1618322fe, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=王树森教授：西达本胺为HR+/HER2-乳腺癌带来治疗革新，中国原创新药助力乳腺癌长期生存, objectType=article, longId=194099, objectId=ae38194099b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae38194099b1, replyNumber=0, likeNumber=90, createdTime=2020-05-15, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae38194099b1, moduleTitle=王树森教授：西达本胺为HR+/HER2-乳腺癌带来治疗革新，中国原创新药助力乳腺癌长期生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae38194099b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618321, encodeId=48ce1618321e1, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=J Clin Med：高强度间歇训练与心力衰竭患者长期生存率提高相关, objectType=article, longId=190447, objectId=420e19044e29, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=420e19044e29, replyNumber=0, likeNumber=61, createdTime=2020-03-21, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=420e19044e29, moduleTitle=J Clin Med：高强度间歇训练与心力衰竭患者长期生存率提高相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=420e19044e29)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618320, encodeId=038e16183202f, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Metabolism：肝移植术后肥胖影响患者长期生存, objectType=article, longId=190147, objectId=65b819014ea1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65b819014ea1, replyNumber=0, likeNumber=65, createdTime=2020-03-18, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65b819014ea1, moduleTitle=Metabolism：肝移植术后肥胖影响患者长期生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65b819014ea1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618319, encodeId=55d51618319c2, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=DCR：肌肉和脂肪组织大肠癌患者长期生存的影响, objectType=article, longId=186983, objectId=f437186983aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f437186983aa, replyNumber=0, likeNumber=96, createdTime=2020-01-31, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f437186983aa, moduleTitle=DCR：肌肉和脂肪组织大肠癌患者长期生存的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f437186983aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618318, encodeId=bc29161831890, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=周彩存教授：少见/罕见突变NSCLC不再无药可用，免疫治疗让部分患者实现长期生存, objectType=article, longId=186207, objectId=30f318620ee4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30f318620ee4, replyNumber=0, likeNumber=59, createdTime=2020-01-15, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30f318620ee4, moduleTitle=周彩存教授：少见/罕见突变NSCLC不再无药可用，免疫治疗让部分患者实现长期生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30f318620ee4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618317, encodeId=8e35161831ee6, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Lancet Oncol：研究5年随访结果显示：帕博利珠单抗为晚期黑色素瘤患者带来长期生存获益, objectType=article, longId=177116, objectId=c4f01e7116dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4f01e7116dc, replyNumber=0, likeNumber=74, createdTime=2019-08-08, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4f01e7116dc, moduleTitle=Lancet Oncol：研究5年随访结果显示：帕博利珠单抗为晚期黑色素瘤患者带来长期生存获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4f01e7116dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618316, encodeId=8f54161831671, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Brit J Surg：肝细胞癌患者肝切除术后感染并发症对长期生存的影响, objectType=article, longId=175546, objectId=3bff1e554626, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bff1e554626, replyNumber=0, likeNumber=98, createdTime=2019-07-17, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bff1e554626, moduleTitle=Brit J Surg：肝细胞癌患者肝切除术后感染并发症对长期生存的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bff1e554626)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618315, encodeId=0a8c1618315be, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=DCR：肌肉和脂肪组织对I期至III期结直肠癌患者长期生存的影响, objectType=article, longId=166623, objectId=ae3c166623b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae3c166623b3, replyNumber=0, likeNumber=50, createdTime=2019-05-24, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae3c166623b3, moduleTitle=DCR：肌肉和脂肪组织对I期至III期结直肠癌患者长期生存的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae3c166623b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618314, encodeId=e07016183148c, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Eur Heart J：心脏再同步治疗患者的长期生存率和晚期心源性猝死, objectType=article, longId=165581, objectId=cfa8165581dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfa8165581dc, replyNumber=0, likeNumber=65, createdTime=2019-05-09, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfa8165581dc, moduleTitle=Eur Heart J：心脏再同步治疗患者的长期生存率和晚期心源性猝死, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfa8165581dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

长期生存

2020-05-29

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

JAHA：左心室心肌致密化不全患者的长期生存率

2021-01-17

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

J Gastroenterology: 肝硬化患者对托伐普坦的持久反应可提高无复发的长期生存率

2020-12-07

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Bluebird突破性基因疗法Lenti-D申请上市！改善致死罕见病CALD患者长期生存结局

2020-10-06

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Br J Cancer：III期临床试验：选择性淋巴结照射和或厄洛替尼联合放化疗改善局部晚期食道鳞状细胞癌患者长期生存率

2020-09-26

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Thorax：无创通气患者的长期生存结局

2020-09-18

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

NEJM：Dabrafenib联合Trametinib 治疗III期黑色素瘤患者长期生存数据喜人

2020-09-05

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Lancet:80岁以上高龄非ST升高的心肌梗死患者接受侵入性治疗后对长期生存有益

2020-09-01

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

J Gastroenterology：对托伐普坦的持久反应可改善肝硬化的长期生存质量

2020-08-29

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Neurology：长期生存的散发型克雅病1例

2020-08-22

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Thorax：家庭可支配收入与肺癌切除术后的长期生存率

2020-06-23

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

赵明芳教授：达可替尼有望助力患者实现高质量长期生存

2020-05-21

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

王树森教授：西达本胺为HR+/HER2-乳腺癌带来治疗革新，中国原创新药助力乳腺癌长期生存

2020-05-15

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

J Clin Med：高强度间歇训练与心力衰竭患者长期生存率提高相关

2020-03-21

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Metabolism：肝移植术后肥胖影响患者长期生存

2020-03-18

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

DCR：肌肉和脂肪组织大肠癌患者长期生存的影响

2020-01-31

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

周彩存教授：少见/罕见突变NSCLC不再无药可用，免疫治疗让部分患者实现长期生存

2020-01-15

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Lancet Oncol：研究5年随访结果显示：帕博利珠单抗为晚期黑色素瘤患者带来长期生存获益

2019-08-08

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Brit J Surg：肝细胞癌患者肝切除术后感染并发症对长期生存的影响

2019-07-17

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

DCR：肌肉和脂肪组织对I期至III期结直肠癌患者长期生存的影响

2019-05-24

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Eur Heart J：心脏再同步治疗患者的长期生存率和晚期心源性猝死

2019-05-09

科室
- - 订阅+
  - 更多科室
工具
服务